68 major congenital malformations were observed in the vaccinated and 53 in the unexposed cohort.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
The risk of hospitalization, intensive care unit (ICU) admission, and death was much lower among more than 9,000 Canadian COVID-19 patients infected with the Omicron variant than among matched Delta patients, according to a study published yesterday in JAMA.
The risk of hospitalization or death with Omicron was 41% of—and the risk of death was one-tenth of—that of Delta.
An analysis of prescribing data from more than 80 countries found that global antimicrobial consumption declined prior to the COVID-19 pandemic, researchers reported today in the Journal of Antimicrobial Chemotherapy.
"We need to ... address these conditions now before they balloon into a much larger mental health crisis."
One study shows more than 90% vaccine protection post-infection, even when the shot follows infection by 18 months.
The University of Wisconsin and Purdue University announce the easing of mask requirements.
A new review of 15 studies analyzed by the UK Health Security Agency (UKHSA) shows COVID-19 vaccination is protective against developing symptoms of long COVID, or symptoms lasting longer than 4 weeks after the initial infection.
Of respondents, 95% say the pandemic revealed drug supply chain vulnerabilities.
Remote trials had 49% racial minority participation, compared with 14% in a clinic-based study.
The BA.2 Omicron subvariant now says makes up about 21% of sequenced global cases, the WHO says.
New cases have dropped 40%, hospitalizations are down 28%, and deaths have decreased by 9%.
